Physician profile
Andrew Murphy
NPI 1821080375
$955.20
in general payments reported to CMS, 2019-2025
12 companies · $83.71 in 2025
The $83.71 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $117 · 2023: $17.31 · 2024: $298 · 2025: $83.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $255.04 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.76 | 2019-2020 | |
| Lilly USA, LLC | $88.76 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $88.53 | 2019-2024 | Keytruda |
| Amgen INC. | $78.90 | 2019 | |
| W. L. Gore & Associates, INC. | $65.78 | 2025 | Gore Tag Conformable Thoracic Stent Graft |
| E.R. Squibb & Sons, L.L.C. | $49.76 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $28.83 | 2019 | |
| Celgene Corporation | $20.44 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.93 | 2025 | Fasenra |
| Baxter Healthcare | $17.31 | 2023 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.